Department of Psychiatry, University of California San Diego, La Jolla, CA 92093-0804, USA.
Pharmacol Biochem Behav. 2012 Jul;102(1):88-94. doi: 10.1016/j.pbb.2012.03.023. Epub 2012 Mar 31.
The indirect serotonin (5-HT) agonist 3,4-methylenedioxymethamphetamine (MDMA) produces a distinct behavioral profile in rats consisting of locomotor hyperactivity, thigmotaxis, and decreased exploration. The indirect 5-HT agonist α-ethyltryptamine (AET) produces a similar behavioral profile. Using the Behavioral Pattern Monitor (BPM), the present investigation examined whether the effects of MDMA and AET are dependent on the novelty of the testing environment. These experiments were conducted in Sprague-Dawley rats housed on a reversed light cycle and tested during the dark phase of the light/dark cycle. We found that racemic MDMA (RS-MDMA; 3 mg/kg, SC) increased locomotor activity in rats tested in novel BPM chambers, but had no effect on locomotor activity in rats habituated to the BPM chambers immediately prior to testing. Likewise, AET (5 mg/kg, SC) increased locomotor activity in non-habituated animals but not in animals habituated to the test chambers. These results were unexpected because previous reports indicate that MDMA has robust locomotor-activating effects in habituated animals. To further examine the influence of habituation on MDMA-induced locomotor activity, we conducted parametric studies with S-(+)-MDMA (the more active enantiomer) in habituated and non-habituated rats housed on a standard or reversed light cycle. Light cycle was included as a variable due to reported differences in sensitivity to serotonergic ligands during the dark and light phases. In confirmation of our initial studies, rats tested during the dark phase and habituated to the BPM did not show an S-(+)-MDMA (3 mg/kg, SC)-induced increase in locomotor activity, whereas non-habituated rats did. By contrast, in rats tested during the light phase, S-(+)-MDMA increased locomotor activity in both non-habituated and habituated rats, although the response in habituated animals was attenuated. The finding that habituation and light cycle interact to influence MDMA- and AET-induced hyperactivity demonstrates that there are previously unrecognized complexities associated with the behavioral effects of these drugs.
间接 5-羟色胺(5-HT)激动剂 3,4-亚甲二氧基甲基苯丙胺(MDMA)在大鼠中产生明显的行为特征,包括运动过度活跃、触壁癖和好动性降低。间接 5-HT 激动剂 α-乙基色胺(AET)也产生类似的行为特征。本研究使用行为模式监测器(BPM)检查 MDMA 和 AET 的作用是否依赖于测试环境的新颖性。这些实验是在居住在相反光照周期中的 Sprague-Dawley 大鼠中进行的,并在光照/黑暗周期的黑暗阶段进行测试。我们发现,外消旋 MDMA(RS-MDMA;3mg/kg,SC)增加了在新 BPM 室中测试的大鼠的运动活性,但对在测试前立即适应 BPM 室的大鼠的运动活性没有影响。同样,AET(5mg/kg,SC)增加了非适应动物的运动活性,但不增加适应测试室的动物的运动活性。这些结果出乎意料,因为先前的报告表明,MDMA 在适应的动物中具有强大的运动激活作用。为了进一步研究适应对 MDMA 诱导的运动活性的影响,我们在居住在标准或相反光照周期的适应和非适应大鼠中进行了 S-(+)-MDMA(更活跃的对映异构体)的参数研究。包括光照周期作为一个变量,是因为据报道在黑暗和光照阶段对 5-HT 配体的敏感性存在差异。与我们的初步研究一致,在黑暗阶段测试并适应 BPM 的大鼠没有表现出 S-(+)-MDMA(3mg/kg,SC)诱导的运动活性增加,而非适应大鼠则表现出运动活性增加。相比之下,在光照阶段测试的大鼠中,S-(+)-MDMA 增加了非适应和适应大鼠的运动活性,尽管适应大鼠的反应减弱。适应和光照周期相互作用影响 MDMA 和 AET 诱导的过度活跃的发现表明,这些药物的行为效应存在以前未被认识到的复杂性。